Literature DB >> 17323041

[Lymphadenectomy for thyroid and lymph node carcinomas].

O Gimm1, H Dralle.   

Abstract

In general, primary surgery of thyroid carcinoma should consist of total thyroidectomy and lymph node dissection of the cervicocentral compartment. Exceptions are cases of papillary microcarcinoma and prophylactic surgery due to multiple type 2A endocrine neoplasia. Lymph node dissection beyond the cervicocentral compartment also should be compartment-oriented. It is generally indicated if lymph node metastases have been proven. Concerning clinically proven medullary thyroid carcinoma, bilateral cervicolateral lymph node dissection is generally indicated, since lymph node metastases may be missed preoperatively but are often found histologically. In patients with parathyroid carcinoma, en bloc ipsilateral cervicocentral lymph node dissection should be performed in addition to parathyroidectomy and hemithyroidectomy. Lymph node dissection should always be performed systematically, since lymph node metastases may be missed both clinically and by imaging techniques.

Entities:  

Mesh:

Year:  2007        PMID: 17323041     DOI: 10.1007/s00104-007-1303-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  38 in total

1.  Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.

Authors:  Isabel Peixoto Callejo; José Américo Brito; Carlos Manuel Zagalo; Jorge Rosa Santos
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

2.  [Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Authors:  O Gimm; K Lorenz; P Nguyen Thanh; U Schneyer; M Bloching; V M Howell; D J Marsh; B T Teh; U Krause; H Dralle
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 3.  The value of lymph-node dissection in patients with differentiated thyroid cancer.

Authors:  S Noguchi; N Murakami
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

4.  Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.

Authors:  J A van Heerden; C S Grant; H Gharib; I D Hay; D M Ilstrup
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

5.  Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma.

Authors:  H W Mueller-Gaertner; H T Brzac; W Rehpenning
Journal:  Cancer       Date:  1991-04-01       Impact factor: 6.860

Review 6.  Surgical strategy for the treatment of medullary thyroid carcinoma.

Authors:  J B Fleming; J E Lee; M Bouvet; P N Schultz; S I Sherman; R V Sellin; K E Friend; M A Burgess; G J Cote; R F Gagel; D B Evans
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

7.  Parathyroid carcinoma.

Authors:  A C Cordeiro; F L Montenegro; M A Kulcsar; L A Dellanegra; M R Tavares; P Michaluart; A R Ferraz
Journal:  Am J Surg       Date:  1998-01       Impact factor: 2.565

8.  Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

Authors:  Jeffrey Liu; Bhuvanesh Singh; Giovanni Tallini; Diane L Carlson; Nora Katabi; Ashok Shaha; R Michael Tuttle; Ronald A Ghossein
Journal:  Cancer       Date:  2006-09-15       Impact factor: 6.860

Review 9.  Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.

Authors:  T Obara; Y Fujimoto
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

10.  Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.

Authors:  H Dralle; I Damm; G F Scheumann; J Kotzerke; E Kupsch; H Geerlings; R Pichlmayr
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more
  4 in total

1.  [Founding a "Lymph Node Metastasis" Study Group at the West German Tumor Center (WTZE)].

Authors:  M Schenck; F vom Dorp; C Boergermann; Y Busch; A Carpinteiro; B Wilker; S Keitsch; K W Schmid; M Groneberg; M Stuschke; H Ruebben; E Gulbins
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

2.  [Globus sensation as a sign of medullary thyroid carcinoma].

Authors:  J Abrams
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

3.  Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision.

Authors:  Agnieszka Czarniecka; Michal Jarzab; Jolanta Krajewska; Ewa Chmielik; Bogna Szcześniak-Klusek; Ewa Stobiecka; Robert Kokot; Aleksander Sacher; Stanisław Poltorak; Jan Wloch
Journal:  Thyroid Res       Date:  2010-10-29

4.  [Lymph node dissection in papillary and follicular thyroid cancer].

Authors:  C Vorländer; R H Lienenlüke; R A Wahl
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.